 |
| |
Join Us at the
MassBio Annual Meeting 2015
|
|
|
|
|
|
|
March 26-27, 2015
Royal Sonesta Hotel, Cambridge, MA
In honor of MassBio's 30 years of innovation, Integrium Clinical Research will be in attendance at the 2015 Annual Meeting, and hopes to meet with healthcare professionals to discuss clinical synergies. The signature event will touch on the most timely and critical challenges facing the state's biotechnology industry. Massachusetts is recognized as the nation's oldest biotechnology trade association, bringing together industry leaders while advancing the development of critical new science. It's no wonder why Integrium has reserved a spot for the 4th year in a row at the MassBio Annual Meeting 2015. To schedule a quick coffee meeting, please contact:
Mike LoftusExecutive Director, Business Development Phone: (908) 295-4578 Email: Mike.Loftus@integrium.com
|
 
Proof of Concept Clinical Trials: Strategy, Design & Execution
Whether your organization is a 100,000 person Pharmaceutical company or a 3 employee Virtual Biotech, we will work with you to help solve patient recruitment and retention difficulties. Our PK Unit and Clinic not only has access to 2,500 healthy volunteers but has a robust database of 7,000+ patients in varying disease states. Consult with us Today! |
The Clinical Expertise You Need
Our Physicians and Business Development Specialists will help evaluate your protocol and clinical trial goals and objectives. We are happy to make recommendations for improvements, and discuss ways to enhance clinical trial success. |
|
 |
Integrium: Providing Alternative Financial Solutions
Integrium Clinical Research specializes in the strategy, study design, and execution of Proof of Concept Clinical Trials for biotechnology companies within a range of therapeutic areas: Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Oncology, Wound Healing, Regenerative, and Orphan Diseases. Integrium offers a turnkey solution to pharmaceutical and biotechnology clients by offering a full range of services that include Study Design and Protocol Development, Project Management, Medical Monitoring, Data Management and Biostatistics.
As an added solution to the traditional cash/services model, Integrium also helps micro-cap, small-cap and privately held pre-IPO biotechs with financing at their next valuation bump by providing new clinical data to assist in the capital raising process. Integrium has partnered with a firm that invests $250,000 - $1.5M in these companies by trading services for equity within a Phase Ib - IIb situation. Contact Us Today To Learn More.
|
| |
|
|
|
|
|
|
|
|
Copyright © 2015. All Rights Reserved.
|
|
|
|
|
